Edition:
United States

Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

483.50DKK
15 Dec 2017
Change (% chg)

kr.-6.50 (-1.33%)
Prev Close
kr.490.00
Open
kr.489.50
Day's High
kr.489.60
Day's Low
kr.482.90
Volume
442,319
Avg. Vol
375,914
52-wk High
kr.594.00
52-wk Low
kr.457.50

Latest Key Developments (Source: Significant Developments)

Coloplast CFO Buys 18,693 Shares In Company For Dkk 5,448,261.78‍​
Monday, 11 Dec 2017 05:26am EST 

Dec 11 (Reuters) - Coloplast ::CFO BUYS 18,693 SHARES IN COMPANY FOR DKK 5,448,261.78‍​.  Full Article

Coloplast sees 2017/2018 revenue growth at lower end of long-term outlook
Thursday, 2 Nov 2017 07:09am EDT 

Nov 2 (Reuters) - COLOPLAST :Q4 REVENUE DKK 3.98‍​ BILLION (REUTERS POLL DKK 4.02 BILLION).Q4 PRETAX PROFIT DKK ‍​1.33 BILLION (REUTERS POLL DKK 1.34 BILLION).‍EXPECT ORGANIC REVENUE GROWTH OF C7% AT CONSTANT EXCHANGE RATES.Q4 EBIT DKK ‍​1.32 BILLION (REUTERS POLL DKK 1.32 BILLION).‍EXPECTS IN 2017/2018 AN EBIT MARGIN OF 31-32% AT CONSTANT EXCHANGE RATES​.‍IN 2017/2018 CAPITAL EXPENDITURE IS EXPECTED TO BE ABOUT DKK 700M AND EFFECTIVE TAX RATE IS EXPECTED TO BE ABOUT 23%​.‍RECOMMENDS TO APPROVE A YEAR-END DIVIDEND OF DKK 10.5 PER SHARE.​.‍INTENDS TO PURSUE INORGANIC GROWTH OPPORTUNITIES TO FURTHER STRENGTHEN ITS SERVICE OFFERING TO CONSUMER​.COLOPLAST - LONG-TERM ‍ORGANIC REVENUE GROWTH GUIDANCE IS MAINTAINED AT 7-9% P.A. WHERE AMBITION IS TO REACH UPPER END OF INTERVAL​.COLOPLAST - LONG-TERM, ‍EBIT MARGIN GUIDANCE REVISED FROM 50-100BP IMPROVEMENT P.A., TO EBIT MARGIN OF >30% AT CONSTANT CURRENCIES​.  Full Article

Coloplast Q3 EBIT, revenue below forecast
Wednesday, 16 Aug 2017 05:57am EDT 

Aug 16 (Reuters) - COLOPLAST A/S :CONTINUE TO EXPECT 2016/17 ORGANIC REVENUE GROWTH OF 7-8% AT CONSTANT EXCHANGE RATES.Q3 REVENUE DKK 3.91‍​ BILLION (REUTERS POLL DKK 4.02 BILLION).Q3 EBIT DKK 1.23‍​ BILLION (REUTERS POLL DKK 1.33 BILLION).GUIDANCE FOR REPORTED 2016/17 REVENUE GROWTH IS REVISED TO 6% IN DKK INSTEAD OF AS PREVIOUSLY 7-8%.2016/17 EBIT MARGIN GUIDANCE REMAINS AT 33-34% AT CONSTANT EXCHANGE RATES.REPORTED 2016/17 EBIT MARGIN GUIDANCE IN DKK IS REVISED TO ABOUT 32% INSTEAD OF AS PREVIOUSLY ABOUT 33%.  Full Article

Coloplast Q2 revenue at DKK 3.88 BLN, in line with expectations
Wednesday, 3 May 2017 05:57am EDT 

May 3 (Reuters) - COLOPLAST ::H1 ORGANIC REVENUE GROWTH WAS 6%.RESOLVED THAT COLOPLAST WILL PAY AN INTERIM DIVIDEND OF DKK 4.50 PER SHARE FOR A DIVIDEND PAY-OUT OF DKK 955M.H1 REVENUE IN DKK WAS UP BY 5% TO DKK 7,636 MILLION."WE CONTINUE TO EXPECT ORGANIC REVENUE GROWTH OF 7-8% AT CONSTANT EXCHANGE RATES AND REPORTED GROWTH OF 7-8% IN DKK".BOARD HAS RESOLVED COLOPLAST WILL PAY INTERIM DIVIDEND OF DKK 4.50PER SHARE FOR DIVIDEND PAY-OUT OF DKK 955 MILLION.EBIT MARGIN GUIDANCE REMAINS AT 33-34% AT CONSTANT EXCHANGE RATES AND AT ABOUT 33% IN DKK.2016/17 CAPITAL EXPENDITURE IS STILL EXPECTED TO BE AROUND DKK 700M.CONTINUE TO EXPECT 2016/17 ORGANIC REVENUE GROWTH OF 7-8% AT CONSTANT EXCHANGE RATES AND REPORTED GROWTH OF 7-8% IN DKK.2016/17 EBIT MARGIN GUIDANCE REMAINS AT 33-34% AT CONSTANT EXCHANGE RATES AND AT ABOUT 33% IN DKK.H1 EBIT UP 8 PERCENT TO DKK 2.47 BILLION.COLOPLAST - FREE CASH FLOW WAS NEGATIVE AT DKK 648M, DKK 1,834M LESS THAN IN SAME PERIOD OF LAST YEAR.Q2 REVENUE DKK 3.88 BILLION (REUTERS POLL DKK 3.89 BILLION).Q2 EBIT DKK 1.25 BILLION (REUTERS POLL DKK 1.27 BILLION).  Full Article

Coloplast Q1 EBIT DKK 1.23 bln, in line with expectations
Wednesday, 1 Feb 2017 06:00am EST 

Coloplast A/S : Q1 organic revenue growth was 6 pct . Q1 revenue 3.76 billion Danish crowns ($545 million)(Reuters poll 3.76 billion crowns) . Q1 EBIT 1.23 billion crowns (Reuters poll 1.22 billion crowns) . Expects revenue growth of 7-8 pct at constant exchange rates and of 7-8 pct in Danish crowns in 2016/17 . Expects an EBIT margin of 33-34 pct, at constant exchange rates and of about 33 pct in Danish crownsin 2016/17 .2016/17 capital expenditure is expected to be about 700 million crowns.  Full Article

Coloplast Q3 EBIT DKK 1.20 billion, below estimates
Tuesday, 16 Aug 2016 06:03am EDT 

Coloplast : Q3 revenue 3.69 billion Danish crowns ($559.15 million) versus 3.72 billion crowns seen in Reuters poll . Q3 EBIT 1.20 billion crowns (Reuters poll 1.22 billion crowns) . Continues to expect organic revenue growth for 2015/16 of 7-8 pct at constant exchange rates and now of about 6 pct in Danish crowns from previously 6-7 pct . Continues to expect EBIT margin to be 33-34 pct at constant exchange rates and to be about 33 pct in Danish crowns for 2015/16 .2015/16 capital expenditure is still expected to be 600-700 million crowns; effective tax rate is still expected to be about 23 pct.  Full Article

Coloplast adjusts downwards 3-yr organic revenue growth outlook
Wednesday, 22 Jun 2016 07:12am EDT 

Coloplast A/S : Says Board approved new long-term financial guidance, spanning three years . Says new target for three years is organic revenue growth of 7-9 pct p.a. . Previous long-term guidance was organic revenue growth of 7-10 pct p.a. . Long-term financial guidance on EBIT-margin remains unchanged - EBIT-margin expansion of 1/2 - 1 percentage points p.a. . Says change in long-term organic revenue growth guidance is explained by challenging macroeconomic environment in emerging markets .Says financial guidance for 2015/16 is unchanged.  Full Article

Coloplast comments on FY 2015/16 outlook
Tuesday, 2 Feb 2016 06:01am EST 

Coloplast A/S:Expects revenue growth of 7-8 pct at constant exchange rates and of around 7 pct in Danish crowns in FY 2015/16.Sees an EBIT margin of 33-34 pct at constant exchange rates and of around 33 pct in Danish crowns in FY 2015/16.  Full Article

BRIEF-Coloplast CFO Buys 18,693 Shares In Company For Dkk 5,448,261.78‍​

* CFO BUYS 18,693 SHARES IN COMPANY FOR DKK 5,448,261.78‍​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)